1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0;14:A0=PAG;21:A0=PAG
2	on	on	IN	_	1	prep	_
3	Sunday	sunday	NNP	_	2	pobj	_
4	made	make	VBD	pb=make.LV	0	root	_
5	an	an	DT	_	9	det	_
6	improved	improved	JJ	_	9	amod	_
7	and	and	CC	_	6	cc	_
8	final	final	JJ	_	6	conj	_
9	offer	offer	NN	p2=VBP	4	dobj	4:AM-PRR
10	worth	worth	JJ	p2=NN	9	amod	_
11	£69	£0	CD	p2=NNP	12	number	_
12	billion	#crd#	CD	_	10	npadvmod	_
13	,	,	,	_	9	punct	_
14	pitched	pitch	VBD	p2=VBN|pb=pitch.04	4	dep	_
15	at	at	IN	_	14	prep	14:AM-LOC
16	£55	£0	CD	p2=NN	15	pobj	_
17	per	per	IN	p2=FW	16	prep	_
18	share	share	NN	_	17	pobj	_
19	,	,	,	_	4	punct	_
20	but	but	CC	_	4	cc	_
21	added	add	VBD	pb=add.01	4	conj	_
22	that	that	IN	_	26	complm	_
23	it	it	PRP	_	26	nsubj	26:A0=PAG
24	would	would	MD	_	26	aux	26:AM-MOD
25	not	not	RB	_	26	neg	26:AM-NEG
26	proceed	proceed	VB	pb=proceed.01	21	ccomp	21:A1=PPT
27	without	without	IN	_	26	prep	26:AM-MNR
28	a	a	DT	_	29	det	_
29	recommendation	recommendation	NN	_	27	pobj	_
30	from	from	IN	_	29	prep	_
31	AstraZenecas	astrazenecas	NNP	p2=JJ	32	nn	_
32	management	management	NN	_	30	pobj	_
33	.	.	.	_	4	punct	_

1	British	british	JJ	_	2	amod	_
2	drugs	drug	NNS	_	7	nsubj	7:A0=PAG;26:A0
3	giant	giant	JJ	p2=NN	4	amod	_
4	AstraZeneca	astrazeneca	NNP	_	2	appos	_
5	on	on	IN	_	2	prep	_
6	Monday	monday	NNP	_	5	pobj	_
7	rejected	reject	VBD	pb=reject.01	0	root	_
8	a	a	DT	_	11	det	_
9	final	final	JJ	_	11	amod	_
10	takeover	takeover	NN	_	11	nn	_
11	bid	bid	NN	p2=VBN	7	dobj	7:A1=PPT
12	from	from	IN	_	11	prep	_
13	US	us	NNP	_	14	nn	_
14	rival	rival	NN	p2=JJ	12	pobj	_
15	Pfizer	pfizer	NNP	_	16	nn	_
16	worth	worth	JJ	p2=VBD	11	amod	_
17	$	$	$	_	19	quantmod	_
18	117	0	CD	_	19	number	_
19	billion	#crd#	CD	_	16	npadvmod	_
20	(	(	-LRB-	_	19	punct	_
21	85	0	CD	_	22	number	_
22	billion	#crd#	CD	_	23	num	_
23	euros	euro	NNS	_	19	appos	_
24	)	)	-RRB-	_	19	punct	_
25	,	,	,	_	7	punct	_
26	saying	say	VBG	pb=say.01	7	advcl	7:AM-PRD
27	it	it	PRP	_	28	nsubj	28:A0=PAG
28	undervalued	undervalue	VBD	pb=undervalue.01	26	ccomp	26:A1=PPT
29	the	the	DT	_	30	det	_
30	firm	firm	NN	_	28	dobj	28:A1=PPT
31	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0;14:A0=PAG;21:A0=PAG
2	on	on	IN	_	1	prep	_
3	Sunday	sunday	NNP	_	2	pobj	_
4	made	make	VBD	pb=make.LV	0	root	_
5	an	an	DT	_	9	det	_
6	improved	improved	JJ	_	9	amod	_
7	and	and	CC	_	6	cc	_
8	final	final	JJ	_	6	conj	_
9	offer	offer	NN	p2=VBP	4	dobj	4:AM-PRR
10	worth	worth	JJ	p2=NN	9	amod	_
11	£69	£0	CD	p2=NNP	12	number	_
12	billion	#crd#	CD	_	10	npadvmod	_
13	,	,	,	_	9	punct	_
14	pitched	pitch	VBD	p2=VBN|pb=pitch.04	4	dep	_
15	at	at	IN	_	14	prep	14:AM-LOC
16	£55	£0	CD	p2=NN	15	pobj	_
17	per	per	IN	p2=FW	16	prep	_
18	share	share	NN	_	17	pobj	_
19	,	,	,	_	4	punct	_
20	but	but	CC	_	4	cc	_
21	added	add	VBD	pb=add.01	4	conj	_
22	that	that	IN	_	26	complm	_
23	it	it	PRP	_	26	nsubj	26:A0=PAG
24	would	would	MD	_	26	aux	26:AM-MOD
25	not	not	RB	_	26	neg	26:AM-NEG
26	proceed	proceed	VB	pb=proceed.01	21	ccomp	21:A1=PPT
27	without	without	IN	_	26	prep	26:AM-MNR
28	a	a	DT	_	29	det	_
29	recommendation	recommendation	NN	_	27	pobj	_
30	from	from	IN	_	29	prep	_
31	AstraZeneca	astrazeneca	NNP	_	33	poss	_
32	's	's	POS	_	31	possessive	_
33	management	management	NN	_	30	pobj	_
34	.	.	.	_	4	punct	_

1	"	"	``	_	48	punct	_
2	We	we	PRP	_	4	nsubj	4:A0=PAG
3	have	have	VBP	_	4	aux	_
4	rejected	reject	VBN	pb=reject.01	48	ccomp	48:A1=PPT
5	Pfizer	pfizer	NNP	_	8	poss	_
6	's	's	POS	_	5	possessive	_
7	final	final	JJ	_	8	amod	_
8	proposal	proposal	NN	_	4	dobj	4:A1=PPT
9	because	because	IN	_	11	mark	_
10	it	it	PRP	_	11	nsubj	15:A0=PAG;11:A1=PPT
11	is	be	VBZ	pb=be.01	4	advcl	4:AM-CAU
12	inadequate	inadequate	JJ	_	11	acomp	11:A2=PRD
13	and	and	CC	_	11	cc	_
14	would	would	MD	_	15	aux	15:AM-MOD
15	present	present	VB	p2=JJ|pb=present.01	11	conj	_
16	significant	significant	JJ	_	17	amod	_
17	risks	risk	NNS	_	15	dobj	15:A1=PPT
18	for	for	IN	_	17	prep	_
19	shareholders	shareholder	NNS	_	18	pobj	_
20	,	,	,	_	15	punct	_
21	while	while	IN	_	23	mark	_
22	also	also	RB	_	23	advmod	_
23	having	have	VBG	pb=have.03	15	advcl	_
24	serious	serious	JJ	_	25	amod	_
25	consequences	consequence	NNS	_	23	dobj	23:A1=PPT
26	for	for	IN	_	25	prep	_
27	the	the	DT	_	28	det	_
28	company	company	NN	_	26	pobj	_
29	,	,	,	_	28	punct	_
30	our	our	PRP$	_	31	poss	_
31	employees	employee	NNS	_	28	conj	_
32	and	and	CC	_	31	cc	_
33	the	the	DT	_	37	det	_
34	life	life	NN	_	36	hmod	_
35	-	-	HYPH	_	36	hyph	_
36	sciences	science	NNS	_	37	nn	_
37	sector	sector	NN	_	31	conj	_
38	in	in	IN	_	37	prep	_
39	the	the	DT	_	40	det	_
40	UK	uk	NNP	_	38	pobj	_
41	,	,	,	_	40	punct	_
42	Sweden	sweden	NNP	_	40	conj	_
43	and	and	CC	_	42	cc	_
44	the	the	DT	_	45	det	_
45	US	us	NNP	_	42	conj	_
46	,	,	,	_	48	punct	_
47	"	"	''	_	48	punct	_
48	said	say	VBD	pb=say.01	0	root	_
49	AstraZeneca	astrazeneca	NNP	_	50	nn	_
50	chairman	chairman	NN	_	52	nn	_
51	Leif	leif	NNP	_	52	nn	_
52	Johansson	johansson	NNP	_	48	nsubj	48:A0
53	.	.	.	_	48	punct	_

1	Pfizer	pfizer	NNP	p2=NN	10	nsubj	4:A0=PAG;10:A0=PAG
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	4	nsubj	4:R-A0
4	makes	make	VBZ	pb=make.02	1	rcmod	_
5	Viagra	viagra	NNP	_	4	dobj	4:A1=PRD
6	,	,	,	_	10	punct	_
7	had	have	VBD	_	8	aux	_
8	on	on	IN	p2=RP	10	prep	10:AM-TMP
9	Friday	friday	NNP	_	8	pobj	_
10	lifted	lift	VBD	pb=lift.01	0	root	_
11	its	its	PRP$	_	12	poss	_
12	proposal	proposal	NN	_	10	dobj	10:A1=PPT
13	to	to	TO	p2=IN	14	aux	_
14	£53.50	£0	VB	p2=CD|pb=£0.01	12	infmod	_
15	per	per	IN	p2=FW	14	prep	_
16	share	share	NN	_	15	pobj	_
17	,	,	,	_	15	punct	_
18	from	from	IN	_	14	prep	14:A3
19	the	the	DT	_	21	det	_
20	previous	previous	JJ	_	21	amod	_
21	level	level	NN	_	18	pobj	_
22	of	of	IN	_	21	prep	_
23	£50	£0	NN	p2=NNS	22	pobj	_
24	.	.	.	_	10	punct	_

1	However	however	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG
4	declared	declare	VBD	pb=declare.02	0	root	_
5	that	that	IN	_	9	complm	_
6	it	it	PRP	_	9	nsubj	12:A0=PAG;9:A1=PPT
7	would	would	MD	_	9	aux	9:AM-MOD
8	only	only	RB	_	9	advmod	9:AM-ADV
9	be	be	VB	pb=be.01	4	ccomp	4:A1=PPT
10	prepared	prepared	JJ	p2=VBN	9	acomp	9:A2=PRD
11	to	to	TO	_	12	aux	_
12	recommend	recommend	VB	pb=recommend.01	10	xcomp	_
13	an	an	DT	_	14	det	_
14	offer	offer	NN	_	12	dobj	12:A1=PPT
15	of	of	IN	_	14	prep	_
16	more	more	JJR	_	18	amod	_
17	than	than	IN	_	18	quantmod	_
18	10	0	CD	_	19	num	_
19	percent	percent	NN	_	15	pobj	_
20	above	above	IN	_	19	prep	_
21	the	the	DT	_	23	det	_
22	£53.50	£0	NN	p2=CD	23	nn	_
23	level	level	NN	_	20	pobj	_
24	,	,	,	_	9	punct	_
25	indicating	indicate	VBG	pb=indicate.01	9	advcl	_
26	a	a	DT	_	27	det	_
27	price	price	NN	_	25	dobj	25:A1=PPT
28	of	of	IN	_	27	prep	_
29	Â£58.85	â£58.85	NNP	p2=NN	28	pobj	_
30	or	or	CC	_	29	cc	_
31	Â£3.85	â£3.85	NNP	p2=CD	29	conj	_
32	more	more	RBR	p2=JJR	12	advmod	_
33	than	than	IN	_	32	prep	_
34	the	the	DT	_	36	det	_
35	latest	late	JJS	_	36	amod	_
36	offer	offer	NN	_	33	pobj	_
37	.	.	.	_	4	punct	_

1	"	"	``	_	27	punct	_
2	The	the	DT	_	4	det	_
3	final	final	JJ	_	4	amod	_
4	proposal	proposal	NN	_	5	nsubj	5:A1=PPT
5	is	be	VBZ	pb=be.01	27	ccomp	27:A1=PPT
6	a	a	DT	_	8	det	_
7	minor	minor	JJ	_	8	amod	_
8	improvement	improvement	NN	_	5	attr	10:A0;12:A1=PPT;24:A1=PPT;5:A2=PRD
9	which	which	WDT	_	10	nsubj	10:R-A0;12:R-A1;24:R-A1
10	continues	continue	VBZ	pb=continue.01	8	rcmod	_
11	to	to	TO	_	12	aux	_
12	fall	fall	VB	pb=fall.01	10	xcomp	10:A1=PPT
13	short	short	RB	p2=JJ	12	advmod	12:A4=GOL
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	Board	board	NNP	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	view	view	NN	_	14	pobj	_
19	of	of	IN	_	18	prep	_
20	value	value	NN	_	19	pobj	_
21	and	and	CC	_	10	cc	_
22	has	have	VBZ	_	24	aux	_
23	been	be	VBN	_	24	auxpass	_
24	rejected	reject	VBN	pb=reject.01	10	conj	_
25	,	,	,	_	27	punct	_
26	"	"	''	_	27	punct	_
27	said	say	VBD	pb=say.01	0	root	_
28	Johansson	johansson	NNP	_	27	nsubj	27:A0
29	.	.	.	_	27	punct	_

1	Under	under	IN	_	9	prep	9:AM-LOC
2	the	the	DT	_	4	det	_
3	latest	late	JJS	_	4	amod	_
4	bid	bid	NN	_	1	pobj	_
5	,	,	,	_	9	punct	_
6	Pfizer	pfizer	NNP	p2=NN	7	nn	_
7	shareholders	shareholder	NNS	_	9	nsubj	9:A0=PAG
8	would	would	MD	_	9	aux	9:AM-MOD
9	own	own	VB	p2=RB|pb=own.01	0	root	_
10	approximately	approximately	RB	_	11	advmod	_
11	73	0	CD	_	13	num	_
12	per	per	NN	p2=IN	13	nn	_
13	cent	cent	NN	_	9	dobj	9:A1=PPT
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	17	det	_
16	new	new	JJ	_	17	amod	_
17	firm	firm	NN	_	14	pobj	_
18	,	,	,	_	9	punct	_
19	while	while	IN	_	26	mark	_
20	the	the	DT	_	22	det	_
21	British	british	JJ	_	22	amod	_
22	group	group	NN	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	shareholders	shareholder	NNS	_	26	nsubj	26:A0=PAG
25	would	would	MD	_	26	aux	26:AM-MOD
26	hold	hold	VB	pb=hold.01	9	advcl	9:AM-ADV
27	27	0	CD	_	28	num	_
28	percent	percent	NN	_	26	dobj	26:A1=PPT
29	.	.	.	_	9	punct	_

1	AstraZeneca	astrazeneca	NNP	_	12	nsubj	6:A0=PAG;12:A0=PAG
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	6	nsubj	6:R-A0
4	has	have	VBZ	_	6	aux	_
5	repeatedly	repeatedly	RB	_	6	advmod	6:AM-MNR
6	snubbed	snub	VBN	p2=JJR|pb=snub.01	1	rcmod	_
7	Pfizer	pfizer	NNP	_	10	poss	_
8	's	's	POS	_	7	possessive	_
9	takeover	takeover	NN	_	10	nn	_
10	attempt	attempt	NN	_	6	dobj	6:A1=PPT
11	,	,	,	_	12	punct	_
12	attacked	attack	VBD	pb=attack.01	0	root	_
13	the	the	DT	_	14	det	_
14	bid	bid	NN	_	12	dobj	12:A1=PPT
15	for	for	IN	_	14	prep	_
16	offering	offer	VBG	p2=NN|pb=offer.01	15	pcomp	_
17	to	to	TO	_	18	aux	_
18	establish	establish	VB	pb=establish.01	16	xcomp	16:A1=PPT
19	its	its	PRP$	_	23	poss	_
20	corporate	corporate	JJ	p2=NN	23	amod	_
21	and	and	CC	_	20	cc	_
22	tax	tax	NN	_	20	conj	_
23	residency	residency	NN	_	18	dobj	18:A1=PPT
24	in	in	IN	_	18	prep	18:AM-LOC
25	England	england	NNP	_	24	pobj	_
26	.	.	.	_	12	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	a	a	DT	_	8	det	_
6	new	new	JJ	_	8	amod	_
7	pharmaceuticals	pharmaceutical	NNS	_	8	nn	_
8	giant	giant	NN	p2=JJ	4	dobj	4:A1=PPT;12:A1
9	which	which	WDT	_	12	nsubjpass	12:R-A1
10	would	would	MD	_	12	aux	12:AM-MOD
11	be	be	VB	_	12	auxpass	_
12	domiciled	domicile	VBN	pb=domicile.01	8	rcmod	_
13	for	for	IN	_	12	prep	12:A2
14	tax	tax	NN	_	15	nn	_
15	purposes	purpose	NNS	_	13	pobj	_
16	in	in	IN	_	15	prep	_
17	Britain	britain	NNP	_	16	pobj	_
18	.	.	.	_	2	punct	_

1	"	"	``	_	32	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	approach	approach	NN	_	10	nsubj	10:A1=PPT;15:A1=PPT
5	throughout	throughout	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	pursuit	pursuit	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	appears	appear	VBZ	pb=appear.02	32	ccomp	32:A1=PPT
11	to	to	TO	_	15	aux	_
12	have	have	VB	_	15	aux	_
13	been	be	VBN	_	15	auxpass	_
14	fundamentally	fundamentally	RB	_	15	advmod	15:AM-MNR
15	driven	drive	VBN	pb=drive.02	10	xcomp	10:C-A1
16	by	by	IN	_	15	agent	15:A0=PAG
17	the	the	DT	_	20	det	_
18	corporate	corporate	JJ	_	20	amod	_
19	financial	financial	JJ	_	20	amod	_
20	benefits	benefit	NNS	_	16	pobj	_
21	to	to	IN	_	20	prep	_
22	its	its	PRP$	_	23	poss	_
23	shareholders	shareholder	NNS	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	cost	cost	NN	p2=JJ	26	nn	_
26	savings	saving	NNS	_	24	pobj	_
27	and	and	CC	_	26	cc	_
28	tax	tax	NN	_	29	nn	_
29	minimisation	minimisation	NN	_	26	conj	_
30	,	,	,	_	32	punct	_
31	"	"	''	_	32	punct	_
32	added	add	VBD	p2=VBN|pb=add.01	0	root	_
33	Johansson	johansson	NNP	_	32	nsubj	32:A0=PAG
34	.	.	.	_	32	punct	_

1	This	this	DT	_	2	nsubj	2:A1=PPT;4:A1=PPT
2	appeared	appear	VBD	pb=appear.02	0	root	_
3	to	to	TO	_	4	aux	_
4	be	be	VB	pb=be.01	2	xcomp	2:C-A1
5	a	a	DT	_	6	det	_
6	reference	reference	NN	_	4	attr	4:A2=PRD
7	to	to	IN	_	6	prep	_
8	big	big	JJ	_	10	amod	_
9	tax	tax	NN	_	10	nn	_
10	charges	charge	NNS	_	7	pobj	13:A1=PPT
11	which	which	WDT	_	13	nsubj	13:R-A1
12	would	would	MD	_	13	aux	13:AM-MOD
13	fall	fall	VB	pb=fall.01	10	rcmod	_
14	due	due	JJ	_	13	advmod	13:A4=GOL
15	on	on	IN	_	13	prep	13:AM-ADV
16	profits	profit	NNS	_	15	pobj	17:A1=PPT
17	held	hold	VBN	pb=hold.01	16	partmod	_
18	abroad	abroad	RB	_	17	advmod	17:AM-LOC
19	should	should	MD	_	21	aux	21:AM-MOD
20	Pfizer	pfizer	NNP	_	21	nsubj	21:A0=PAG;23:A0=PAG
21	decide	decide	VB	pb=decide.01	2	advcl	_
22	to	to	TO	_	23	aux	_
23	transfer	transfer	VB	pb=transfer.01	21	xcomp	21:A1=PPT
24	them	them	PRP	_	23	dobj	23:A1=PPT
25	to	to	IN	_	23	prep	23:A2=GOL
26	the	the	DT	_	28	det	_
27	United	united	NNP	_	28	nn	_
28	States	states	NNP	_	25	pobj	_
29	.	.	.	_	2	punct	_

1	"	"	``	p2=''	38	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	38	ccomp	38:A1=PPT
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	,	,	,	_	38	punct	_
37	Johansson	johansson	NNP	_	38	nsubj	38:A0
38	said	say	VBD	pb=say.01	0	root	_
39	.	.	.	_	38	punct	_

